Shanghai Pulmonary Hospital, Shanghai, China clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 157 studies whose lead sponsor is Shanghai Pulmonary Hospital, Shanghai, China. 94 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 15, 2026.
Keep track of what changes. Save the Shanghai Pulmonary Hospital, Shanghai, China studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesStatus
Where
- China
- 120
Focus areas
Conditions Shanghai Pulmonary Hospital, Shanghai, China leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 157. Browse all 157 →
- Effectiveness and Safety of MRG003 (Becotatug Vedotin) in Relapsed SCLCRecruitingNCT07874581Not applicable
- Neoadjuvant Iruplinalkib and Bevacizumab in ALK-positive NSCLC: A Phase II Single-arm TrialNot yet recruitingNCT07870733Not applicable
- Neoadjuvant Chemotherapy Combined With Bispecific Antibody Versus Combined With Monoclonal Antibody in Locally Advanced NSCLCRecruitingNCT07863999Phase 3
- T2AIR: Real-World Efficacy and Safety of Biologics Targeting Type 2 Inflammation in Asthma and COPDRecruitingNCT07823842
- Inspiratory Flow Rate Capability in Pulmonary Fibrosis PatientsRecruitingNCT07820254
- Oral Paclitaxel Solution With Immunotherapy and Concurrent SBRT as Neoadjuvant Treatment for Older Adults With NSCLCRecruitingNCT07754812Phase 4
- Impact of Sugammadex Versus Neostigmine on Early Postoperative Pulmonary FunctionRecruitingNCT07309393Not applicable
- Neoadjuvant SF-SBRT Plus Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC.Not yet recruitingNCT07608159Phase 3
- Oral Paclitaxel as Neoadjuvant Therapy in Elderly NSCLC: A Phase II TrialNot yet recruitingNCT07599163Not applicable
- Application of Electromagnetic Navigation System in Pulmonary Nodule LocalizationNot yet recruitingNCT07595120Not applicable
- Neoadjuvant Treatment For Locally Advanced Thymic CancerRecruitingNCT06019468Phase 2
- Nab-Paclitaxel Combined With Local Therapy in Relapsed SCLCNot yet recruitingNCT07547332Phase 2
- Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cmRecruitingNCT04937283Not applicable
- Combining Furmonertinib With Local Therapy for Inoperable Early-stage Lung Cancer: A Phase II TrialNot yet recruitingNCT07517640Phase 2
- Thoracic Surgery Intercostal Block Trial With Liposomal vs. Hydrochloride BupivacaineRecruitingNCT07134660Not applicable
- TEAS for Ipsilateral Shoulder Pain After Video-Assisted Thoracoscopic Lung SurgeryNot yet recruitingNCT07494591Not applicable
- Study on the Efficacy and Safety of JSKN016 as Neoadjuvant Therapy in Resectable Stage II-III Non-small Cell Lung Cancer PatientsNot yet recruitingNCT07493980Phase 2
- A Clinical Trial on the Outcomes of Comprehensive Enhanced Prophylaxis Management (CEPM) in Chinese Patients With EGFR-Mutated Advanced NSCLC Receiving Amivantamab-Based RegimensNot yet recruitingNCT07469488Phase 4
- Efficacy of Anti-CTLA-4 Antibody Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy for Resectable Stage II-III Non-Small Cell Lung CancerRecruitingNCT07410975Phase 2
- IBI363 (PD-1/IL-2α-bias) in Combination With Chemotherapy as Neoadjuvant Therapy in Initially Unresectable Stage III Non-Small Cell Lung CancerRecruitingNCT07408635Phase 2
- Acetohydroxamic Acid Combined With a Short-Course Regimen for MDR-TB (AHA-PLUS)Not yet recruitingNCT07393438Phase 2
- Intrapleural Bupivacaine Analgesia for Postoperative Pain Management After Minimally Invasive Video-Assisted Thoracoscopic Surgery: A Randomized Controlled TrialNot yet recruitingNCT07393386Phase 4
- A Multi-modal Integrating Imaging and Cell-free DNA Methylation in Lung Cancer Early Detection (CMe-Lung): a Multi-center, Observational StudyNot yet recruitingNCT07375979
- Patient-derived Tumor-like Cell Cluster Model-based Precision Treatment Strategy on Non-small Cell Lung CancerRecruitingNCT07328945
- Neoadjuvant Sacituzumab Tirumotecan and Limertinib for Potentially Resectable Stage Ⅲ EGFR-mutant Non-small Cell Lung CancerRecruitingNCT07323056Phase 2
- Post-line Treatment With Teniposide for c-Myc-driven Extensive-stage Small Cell Lung CancerRecruitingNCT06758700Phase 2
- The C-BRIDGE Study: China Bronchiectasis Research Involving Databases, Genomics, and EndotypingRecruitingNCT06900062
- Synthetic PET From CT Improves Precision Diagnosis and Treatment of Lung Cancer: a Prospective, Observational, Multicenter StudyRecruitingNCT07243873
- Ensartinib After Chemoradiotherapy in Stage III ALK-Mutated NSCLCNot yet recruitingNCT07235306Phase 2
- Segmentectomy vs Lobectomy for 2 - 3cm IASLC Grade 1-2 Lung Adenocarcinoma: A Multi-center RCTNot yet recruitingNCT07169903Phase 3
- Efficacy and Safety of Huanjingjian Decoction in Women With Premature Ovarian InsufficiencyNot yet recruitingNCT07020429Not applicable
- Bozitinib Combined With Chemotherapy as Radical Treatment for Stage IIA-IIIC MET-Altered Non-Small Cell Lung CancerNot yet recruitingNCT07153770Phase 2
- Efficacy and Safety of Early Antifibrotic Therapy for Non-progressive Fibrotic Interstitial Lung DiseaseNot yet recruitingNCT07141810Phase 4
- Short-Course Regimen With Bedaquiline, Moxifloxacin and Pyrazinamide for Early Bactericidal Activity in Drug-Susceptible TuberculosisNot yet recruitingNCT07129629Phase 2
- A Prospective, Multicenter Clinical Study of Hetrombopag in the Prevention of Thrombocytopenia Caused by Lung Cancer TherapyNot yet recruitingNCT07101627Phase 2
- Toripalimab Combined With Chemotherapy as Adjuvant Therapy for Incidental Small Cell Lung Cancer After Radical Resection of Lung Cancer: A Single-Center, Randomized Controlled Clinical Study Protocol Number: LungMate-033Not yet recruitingNCT07097948Phase 2
- The Effect of Semi-recumbent Position on Hypoxemia After Lung Segment/Lobe SurgeryEnrolling by invitationNCT07060625
- Neoadjuvant Sugemalimab + Chemotherapy Followed by Adjuvant Sugemalimab for Patients With Resectable Stage II-IIIA Non-small-cell Lung Cancer PatientsRecruitingNCT06987734Phase 2
- Comparison of Neoadjuvant Cadonilimab Versus Chemotherapy Combined With PD-1 in the Treatment of Resectable Non-Small Cell Lung Cancer With High PD-L1 Expression: A Single-Center, Randomized, Exploratory Clinical StudyNot yet recruitingNCT06946836Phase 2
- Long-term Impact of Inhaled Tobramycin for Pseudomonas Aeruginosa Eradication in Bronchiectasis (ERASE II)RecruitingNCT06760273
- Neoadjuvant Chemotherapy Combined With Bispecific Antibody Versus Monoclonal Antibody in Locally Advanced NSCLCNot yet recruitingNCT06837948Phase 2
- A Study on the Efficacy of Atezolizumab Combined with ChemotherapyRecruitingNCT06780826
- The Efficacy and Safety of Ensartinib As Adjuvant Therapy in Stage I ALK-positive NSCLC Patients with High Risk FactorsNot yet recruitingNCT06772610Phase 2
- Disitamab Vedotin in Combination with Tislelizumab and Bevacizumab in a Phase II Clinical Study of Locally Advanced or Metastatic Non-small Cell Lung Cancer with HER2 Mutation/amplification/expressionRecruitingNCT06749860Phase 2
- An Exploratory Study of Tislelizumab in Combination with Chemotherapy in Immuno-experienced Patients with EGFR/ALK/ROS1-negative Advanced NSCLC in the Second-line SettingRecruitingNCT06749886Phase 2
- The Incidence and Risk Factors of Central Nervous System Adverse Events of Lorlatinib in Patients with ALK-positive Advanced Non-small Cell Lung Cancer: a Real-world StudyNot yet recruitingNCT06652555
- WSI Based DL for Diagnosing the IASLC Grading System of Lung AdenocarcinomaRecruitingNCT05925764
- Vebreltinib for Neoadjuvant in MET-altered Stage IIIA-IIIB (N2) Non-small Cell Lung Cancer (NSCLC)Not yet recruitingNCT06644313Phase 2
- Efficacy of PD-1 Inhibitor Combination Therapy in Non-small Cell Lung Cancer Patients Who Have Not Achieved Major Pathologic Response After Neoadjuvant Immunotherapy: a Multicenter, Phase II Clinical TrialNot yet recruitingNCT06620822Phase 2
- A Phase II Study of Ivonescimab Combined with Cadonilimab and Chemotherapy in Extensive-stage Small Cell Lung CancerNot yet recruitingNCT06620796Phase 2